Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Glancy Binkow & Goldberg Llp
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Anadigics, Inc., Announces an Expanded Class Period in the Shareholder Lawsuit
December 7th, 2008
Glancy Binkow & Goldberg LLP -- representing shareholders of Anadigics, Inc. -- has expanded the Class Period in the shareholder lawsuit filed in the United States District Court for the District of New Jersey to include all persons or entities who purchased or otherwise acquired the securities of Anadigics, Inc. ("Anadigics" or the "Company") (NASDAQ:ANAD) between February 12, 2007 and October 22, 2008, inclusive (the "Class Period"). A copy of the Complaint is available from the court or from Glancy Binkow & Goldberg LLP. Please contact us by phone to discuss this action or to obtain a copy of the Complaint at (310) 201-9150 or Toll Free at (888) 773-9224, by email at...
Source: Pharma Investments, Ventures & Law Weekly (2008-12-07)
|
